RAPHAS Co., Ltd. engages in the research, development and sale of microarray patches. Its products include pharmaceutical and cosmetic patches. It distributes under the Acropass brand. The company was founded on March 30, 2006 and is headquartered in Seoul, South Korea.
Fundamental metrics to determine fair value of the stock
Company’s recent performance and margins
Dividend yield, history and sustainability
Financial position and solvency of the company